In partnership with pharmaceutical companies and in accordance with the law, EPS supports drug development from various angles by monitoring, processing, and analyzing data.
Another EPS feature is its strength in providing all kinds of support services related to clinical trials and covering a wide range of disease areas.
With the ever-changing environment, we focus on training professionals who can respond to a variety of situations.
Recently, the "Virtual Go" concept, which promotes virtual clinical trials, has been at the core of our efforts to improve the efficiency and reduce the burden of clinical monitoring, and to provide higher quality data by improving the convenience and satisfaction of patients.
EPS stands for Ever Progressing System, which represents our will to never stop improving. Based on this philosophy, we will continue to strive to be a company that take on valuable challenges every day.
What is EPS
By phase of study
Statistical period:October, 2020 – March, 2024
Number of protocols by business:2,563case
*Percentages are based on the total number of protocols.
* Please scroll horizontally to see.
By therapeutic areas
Statistical period:October, 2020 – March, 2024
Number of protocols by business:2,563case
*Percentages are based on the total number of protocols.
* Please scroll horizontally to see.
By type of service
Statistical period:October, 2020 – March, 2024
*Percentages are based on the total contract amount.
*Monitoring includes Feasibility studies, etc.
* Please scroll horizontally to see.
Regenerative Medicine of Contract Results
By therapeutic areas
Statistical period:October, 2020 – March, 2024
Number of protocols by business:62case
*Percentages are based on the total number of protocols.
* Please scroll horizontally to see.